THAR PHARMACEUTICALS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2008-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://tharpharma.com
Open Label Dose Escalation Phase I Study to Investigate the Safety and Pharmacokinetics of T121E01F and T121E02F in Healthy Postmenopausal Women
- First Posted Date
- 2012-11-06
- Last Posted Date
- 2015-03-26
- Lead Sponsor
- Thar Pharmaceuticals, Inc
- Target Recruit Count
- 71
- Registration Number
- NCT01721993
- Locations
- 🇺🇸
Prism Clinical Research, St. Paul, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath